Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis

Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis

<p>Abstract</p> <p>Background</p> <p>In Israel, an average of 37 children are born each year with sepsis and another four with meningitis as a result of Group B Streptococcal (GBS) disease. Israel currently only screens mothers with defined risk factors (around 15% of a...

Full description

Bibliographic Details
Main Authors: Ginsberg Gary M, Eidelman Arthur I, Shinwell Eric, Anis Emilia, Peyser Reuven, Lotan Yoram
Format: Article
Language:English
Published: BMC 2013-02-01
Series:Israel Journal of Health Policy Research
Subjects:
Cost utility analysis
Group B streptococcal disease
Screening
Intrapartum antiobiotic prophyhlaxis
Online Access:http://www.ijhpr.org/content/2/1/6

Internet

http://www.ijhpr.org/content/2/1/6

Similar Items